Varicella infection after heart and lung transplantation: a single-center experience

J Heart Lung Transplant. 2007 Apr;26(4):399-402. doi: 10.1016/j.healun.2007.01.007.

Abstract

Disseminated varicella-zoster virus infection after organ transplantation in adults is a rare but serious event causing significant morbidity and mortality. We describe our 10-year experience of 13 cases in a single center, including risk factors for infection, lack of protection from pre-existing anti-varicella-zoster virus antibodies, and unusual modes of presentation, including disseminated intravascular coagulation. We also report our preliminary observation of resolution of infection without sequelae in 4 patients with severe disseminated varicella-zoster virus infection who were treated with the combination of intravenous acyclovir and polyspecific intravenous immunoglobulin.

MeSH terms

  • Acyclovir / therapeutic use
  • Adult
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use
  • Disseminated Intravascular Coagulation / virology
  • Drug Therapy, Combination
  • Female
  • Heart-Lung Transplantation / adverse effects*
  • Heart-Lung Transplantation / mortality
  • Herpes Zoster / complications
  • Herpes Zoster / drug therapy
  • Herpes Zoster / etiology*
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Pulmonary Fibrosis / complications
  • Pulmonary Fibrosis / virology
  • Respiratory Insufficiency / etiology
  • Respiratory Insufficiency / mortality
  • Retrospective Studies

Substances

  • Antiviral Agents
  • Immunoglobulins, Intravenous
  • Acyclovir